Alerts Sign-up
Riverside Healthcare has been acknowledged by the American Heart Association for its efforts in enhancing care for aortic stenosis, a significant heart valve disease. The healthcare provider received the Target: Aortic Stenosis Honor Roll award, recognizing their commitment to improving outcomes for this condition.
Aortic stenosis is prevalent among Americans over 65, with more than 1.7 million affected. Without valve replacement, survival rates drop significantly within two years. Many remain undiagnosed or unaware of their condition, prompting initiatives from the American Heart Association to promote timely diagnosis and treatment.
Benjamin McLain, Riverside Vice President of Operations, expressed pride in the recognition: “We are proud to be recognized for our team’s dedication to improving heart valve disease care and treatment.” He highlighted that the program aids in optimizing treatment pathways involving patients, caregivers, and providers.
The American Heart Association's Target: Aortic Stenosis program aims to enhance patient outcomes from symptom onset through appropriate treatment. It includes developing evidence-based measures and providing educational resources for both patients and healthcare professionals.
Gregg Fonarow, M.D., FAHA of the American Heart Association noted that undertreatment of symptomatic severe aortic stenosis adversely affects symptoms and survival rates. He emphasized that understanding aortic stenosis through the program allows healthcare organizations to ensure timely and appropriate patient care.
Further information can be found at heart.org/TargetAS.
The American Heart Association has been a leading health information source for over a century. With support from millions globally, it funds research and advocates for public health improvements related to cardiovascular disease and stroke.
